Biosurv International LTD

Biosurv International LTD is a woman-owned, not-for-profit corporate entity based in Salisbury, United Kingdom, that provides specialized bioinformatics services to the U.S. federal government. The company is registered in SAM.gov and maintains current federal contracting eligibility through June 19, 2026. Biosurv International LTD has established itself as a supplier of advanced computational and analytical solutions in the life sciences sector, with particular expertise in infectious disease diagnostics and pathogen identification methodologies.

The company has received three firm fixed-price purchase orders from the U.S. Navy Bureau of Medicine and Surgery, totaling $502,703.96 in federal contract awards since August 2023. The initial contract, awarded on August 11, 2023, valued at $111,650.00, involved providing bioinformatics analysis services with a completion date of February 14, 2024, performed in Great Britain. A second contract awarded on July 18, 2024, for $243,265.00, focused on the development of bioinformatics protocols with an ultimate completion date of July 28, 2025. The most recent award, dated September 4, 2025, in the amount of $147,788.96, involves developing bioinformatics protocols capable of agnostic detection of bacterial versus viral diseases, with performance scheduled in New Guinea and completion targeted for September 28, 2026. All three contracts were awarded without set-aside designations, indicating they were competed on an unrestricted basis. The contracts collectively demonstrate Biosurv International LTD's core competency in developing sophisticated computational diagnostic tools and analytical methodologies that support the Department of Defense's medical research objectives, antimicrobial stewardship initiatives, and pandemic preparedness capabilities within military medical operations.